However, a review of the available literature suggests that researchers have previously dosed it in the following ways [2]: GHK-Cu Dose: 1-2 mg per day, injected subcutaneously or intramuscularly
What Remains Essential With or Without Medication Thorough medical evaluation and ongoing clinician supervision Sustainable diet and physical activity changes Patience with realistic timelines, as trials evaluated outcomes over 64 weeks or longer Awareness of potential risks and side effects Individual results vary widely based on adherence, lifestyle factors, medical history, and biological response
They can provide interim access during insurance appeals or serve as a longer-term affordable option if your plan denies coverage
Hypoglycemia is a recognized risk because IGF-1 has insulin-mimetic properties at the receptor level
Cloudiness, particles, unusual color, or foul odor indicate contamination or degradation
doi: 10.1006/taap.2002.9450